CA2072484A1 - Use of nadh or nadph against cancer and aids - Google Patents

Use of nadh or nadph against cancer and aids

Info

Publication number
CA2072484A1
CA2072484A1 CA002072484A CA2072484A CA2072484A1 CA 2072484 A1 CA2072484 A1 CA 2072484A1 CA 002072484 A CA002072484 A CA 002072484A CA 2072484 A CA2072484 A CA 2072484A CA 2072484 A1 CA2072484 A1 CA 2072484A1
Authority
CA
Canada
Prior art keywords
nadh
nadph
aids
against cancer
nicotinamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002072484A
Other languages
French (fr)
Other versions
CA2072484C (en
Inventor
Jorg Birkmayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2072484A1 publication Critical patent/CA2072484A1/en
Application granted granted Critical
Publication of CA2072484C publication Critical patent/CA2072484C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Use of nicotinamide-adenine dinucleotide (NADH), nicotinamide-adenine dinucleotide phosphate (NADPH) or a physiologically compatible salt thereof for the treatment of cancer or AIDS.
CA002072484A 1991-08-26 1992-06-26 Use of nadh or nadph against cancer and aids Expired - Fee Related CA2072484C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4128625.1 1991-08-26
DE4128625A DE4128625A1 (en) 1991-08-26 1991-08-26 MEDICINE AGAINST CANCER AND AIDS

Publications (2)

Publication Number Publication Date
CA2072484A1 true CA2072484A1 (en) 1993-02-27
CA2072484C CA2072484C (en) 2002-02-26

Family

ID=6439356

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002072484A Expired - Fee Related CA2072484C (en) 1991-08-26 1992-06-26 Use of nadh or nadph against cancer and aids

Country Status (13)

Country Link
EP (1) EP0534097B1 (en)
JP (1) JP3493202B2 (en)
AT (1) ATE150313T1 (en)
AU (1) AU653619B2 (en)
BR (1) BR9203302A (en)
CA (1) CA2072484C (en)
DE (2) DE4128625A1 (en)
DK (1) DK0534097T3 (en)
ES (1) ES2099772T3 (en)
GR (1) GR3023191T3 (en)
HU (1) HUT61895A (en)
NO (1) NO300915B1 (en)
ZA (1) ZA924902B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU744902B2 (en) * 1997-09-11 2002-03-07 Oxigene, Inc. Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
US20040126751A1 (en) * 2002-12-27 2004-07-01 Birkmayer Jorg G.D. Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1162938B (en) * 1983-08-26 1987-04-01 Dino Spisni COMPOSITION FOR THE TREATMENT OF MALIGNANT CANCERS, IN PARTICULAR ON ANIMALS
US4970200A (en) * 1988-03-01 1990-11-13 Schering Aktiengesellschaft Agent for treatment of Parkinson's disease

Also Published As

Publication number Publication date
DE4128625C2 (en) 1993-08-12
BR9203302A (en) 1993-03-30
JPH072678A (en) 1995-01-06
AU2125392A (en) 1993-03-04
HUT61895A (en) 1993-03-29
JP3493202B2 (en) 2004-02-03
GR3023191T3 (en) 1997-07-30
NO300915B1 (en) 1997-08-18
CA2072484C (en) 2002-02-26
DE59208223D1 (en) 1997-04-24
ATE150313T1 (en) 1997-04-15
DE4128625A1 (en) 1993-04-08
DK0534097T3 (en) 1997-09-22
ES2099772T3 (en) 1997-06-01
AU653619B2 (en) 1994-10-06
ZA924902B (en) 1993-04-28
EP0534097A3 (en) 1993-07-14
EP0534097B1 (en) 1997-03-19
EP0534097A2 (en) 1993-03-31
NO923324D0 (en) 1992-08-25
NO923324L (en) 1993-03-01

Similar Documents

Publication Publication Date Title
USD302400S (en) Earring
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
CA2019812A1 (en) Novel 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of aids
USD305996S (en) Earring
CA2105912A1 (en) NADH and NADPH as Drugs for Treating Alzheimer's Disease
EP0345248A3 (en) Use of the enzyme-cofactor nadph in the preparation of a pharmaceutical, pharmaceutical and preparation thereof
USD310248S (en) Game playing card
USD321055S (en) Caliper for dental implants
CA2072484A1 (en) Use of nadh or nadph against cancer and aids
CA2059510A1 (en) Use of nadh and nadph as energy substitutes
AU9010991A (en) Antidepressant
USD301563S (en) Charm or the like
USD300343S (en) Removable cheek rest for a rifle stock
USD306052S (en) Abduction-adduction hip exerciser
USD330569S (en) Golf chipping practice target
USD306636S (en) Gun grip
USD293818S (en) Keratometer or the like
USD296835S (en) Vest
USD298843S (en) Inflatable koala bear figure
USD307401S (en) Badge
USD306634S (en) Gun grip
USD316404S (en) Magnet
USD303073S (en) Offset body hammer
USD296117S (en) Gameboard
USD309973S (en) Cross

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed